Detalhe da pesquisa
1.
Association Between Autoimmune Diseases and Monoclonal Gammopathy of Undetermined Significance : An Analysis From a Population-Based Screening Study.
Ann Intern Med
; 2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38768457
2.
Development of a Multivariable Model to Predict the Need for Bone Marrow Sampling in Persons With Monoclonal Gammopathy of Undetermined Significance : A Cohort Study Nested in a Clinical Trial.
Ann Intern Med
; 177(4): 449-457, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38560901
3.
Carfilzomib, thalidomide, and dexamethasone is safe and effective in relapsed and/or refractory multiple myeloma: final report of the single arm, multicenter phase II ALLG MM018/AMN002 study.
Haematologica
; 2024 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38235519
4.
Prior cancer and risk of monoclonal gammopathy of undetermined significance: a population-based study in Iceland and Sweden.
Haematologica
; 2024 Jan 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38205512
5.
Management of multiple myeloma-related renal impairment: recommendations from the International Myeloma Working Group.
Lancet Oncol
; 24(7): e293-e311, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37414019
6.
Clinical perspectives on the optimal use of lenalidomide plus bortezomib and dexamethasone for the treatment of newly diagnosed multiple myeloma.
Haematologica
; 108(11): 2894-2912, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37608773
7.
Disease associations with monoclonal gammopathy of undetermined significance can only be evaluated using screened cohorts: results from the population-based iStopMM study.
Haematologica
; 108(12): 3392-3398, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37439374
8.
Patient and Caregiver Experience Decision Factors in Treatment Decision Making: Results of a Systematic Literature Review of Multiple Myeloma Decision Aids.
Value Health
; 26(1): 39-49, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35613958
9.
Treatment of multiple myeloma-related bone disease: recommendations from the Bone Working Group of the International Myeloma Working Group.
Lancet Oncol
; 22(3): e119-e130, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33545067
10.
Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group.
Lancet Oncol
; 22(3): e105-e118, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33662288
11.
Effect of initial treatment on health-related quality of life in patients with newly diagnosed multiple myeloma without immediate stem cell transplant intent: results from the Connect® MM Registry.
Br J Haematol
; 193(1): 93-100, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33118614
12.
Association between race and treatment patterns and survival outcomes in multiple myeloma: A Connect MM Registry analysis.
Cancer
; 126(19): 4332-4340, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32706404
13.
Multiple Myeloma Incidence and Mortality Around the Globe; Interrelations Between Health Access and Quality, Economic Resources, and Patient Empowerment.
Oncologist
; 25(9): e1406-e1413, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32335971
14.
Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma.
Blood
; 132(6): 587-597, 2018 08 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29884741
15.
Daratumumab-lenalidomide-dexamethasone vs standard-of-care regimens: Efficacy in transplant-ineligible untreated myeloma.
Am J Hematol
; 95(12): 1486-1494, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32804408
16.
International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders.
Lancet Oncol
; 20(6): e302-e312, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31162104
17.
Development of a prognostic model for overall survival in multiple myeloma using the Connect® MM Patient Registry.
Br J Haematol
; 187(5): 602-614, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31382320
18.
Circulating tumor DNA and bone marrow minimal residual disease negativity confers superior outcome for multiple myeloma patients.
Haematologica
; 109(3): 974-978, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37767561
19.
Survival differences in multiple myeloma in Latin America and Asia: a comparison involving 3664 patients from regional registries.
Ann Hematol
; 98(4): 941-949, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30729281
20.
Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study.
Lancet Oncol
; 19(3): 370-381, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29429912